Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization

M. Shigyo, Y. Kobayashi, O. Platoshyn, S. Marsala, T. Kato, N. Takamura, K. Yoshida, A. Kishino, M. Bravo-Hernandez, S. Juhas, J. Juhasova, H. Studenovska, V. Proks, JD. Ciacci, M. Marsala

. 2023 ; 32 (-) : 9636897231163232. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004676

The critical requirements in developing clinical-grade human-induced pluripotent stem cells-derived neural precursors (hiPSCs-NPCs) are defined by expandability, genetic stability, predictable in vivo post-grafting differentiation, and acceptable safety profile. Here, we report on the use of manual-selection protocol for generating expandable and stable human NPCs from induced pluripotent stem cells. The hiPSCs were generated by the reprogramming of peripheral blood mononuclear cells with Sendai-virus (SeV) vector encoding Yamanaka factors. After induction of neural rosettes, morphologically defined NPC colonies were manually harvested, re-plated, and expanded for up to 20 passages. Established NPCs showed normal karyotype, expression of typical NPCs markers at the proliferative stage, and ability to generate functional, calcium oscillating GABAergic or glutamatergic neurons after in vitro differentiation. Grafted NPCs into the striatum or spinal cord of immunodeficient rats showed progressive maturation and expression of early and late human-specific neuronal and glial markers at 2 or 6 months post-grafting. No tumor formation was seen in NPCs-grafted brain or spinal cord samples. These data demonstrate the effective use of in vitro manual-selection protocol to generate safe and expandable NPCs from hiPSCs cells. This protocol has the potential to be used to generate GMP (Good Manufacturing Practice)-grade NPCs from hiPSCs for future clinical use.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004676
003      
CZ-PrNML
005      
20230425171643.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/09636897231163232 $2 doi
035    __
$a (PubMed)36959733
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Shigyo, Michiko $u Department of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA
245    10
$a Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization / $c M. Shigyo, Y. Kobayashi, O. Platoshyn, S. Marsala, T. Kato, N. Takamura, K. Yoshida, A. Kishino, M. Bravo-Hernandez, S. Juhas, J. Juhasova, H. Studenovska, V. Proks, JD. Ciacci, M. Marsala
520    9_
$a The critical requirements in developing clinical-grade human-induced pluripotent stem cells-derived neural precursors (hiPSCs-NPCs) are defined by expandability, genetic stability, predictable in vivo post-grafting differentiation, and acceptable safety profile. Here, we report on the use of manual-selection protocol for generating expandable and stable human NPCs from induced pluripotent stem cells. The hiPSCs were generated by the reprogramming of peripheral blood mononuclear cells with Sendai-virus (SeV) vector encoding Yamanaka factors. After induction of neural rosettes, morphologically defined NPC colonies were manually harvested, re-plated, and expanded for up to 20 passages. Established NPCs showed normal karyotype, expression of typical NPCs markers at the proliferative stage, and ability to generate functional, calcium oscillating GABAergic or glutamatergic neurons after in vitro differentiation. Grafted NPCs into the striatum or spinal cord of immunodeficient rats showed progressive maturation and expression of early and late human-specific neuronal and glial markers at 2 or 6 months post-grafting. No tumor formation was seen in NPCs-grafted brain or spinal cord samples. These data demonstrate the effective use of in vitro manual-selection protocol to generate safe and expandable NPCs from hiPSCs cells. This protocol has the potential to be used to generate GMP (Good Manufacturing Practice)-grade NPCs from hiPSCs for future clinical use.
650    _2
$a lidé $7 D006801
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a zvířata $7 D000818
650    12
$a indukované pluripotentní kmenové buňky $7 D057026
650    12
$a nervové kmenové buňky $7 D058953
650    _2
$a virus Sendai $x genetika $7 D029082
650    _2
$a leukocyty mononukleární $7 D007963
650    _2
$a neurony $x metabolismus $7 D009474
650    _2
$a buněčná diferenciace $7 D002454
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kobayashi, Yoshiomi $u Department of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA $u Murayama Medical Center, Department of Orthopaedic Surgery, Tokyo, Japan
700    1_
$a Platoshyn, Oleksandr $u Department of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA
700    1_
$a Marsala, Silvia $u Department of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA
700    1_
$a Kato, Tomohisa $u Regenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan $u Division of Stem Cell Medicine, Department of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Uchinada, Japan
700    1_
$a Takamura, Naoki $u Regenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan
700    1_
$a Yoshida, Kenji $u Regenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan
700    1_
$a Kishino, Akiyoshi $u Regenerative & Cellular Medicine Kobe Center, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Japan
700    1_
$a Bravo-Hernandez, Mariana $u Department of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA
700    1_
$a Juhas, Stefan $u Institute of Animal Physiology and Genetics AS CR, v.v.i., Liběchov, Czech Republic
700    1_
$a Juhasova, Jana $u Institute of Animal Physiology and Genetics AS CR, v.v.i., Liběchov, Czech Republic
700    1_
$a Studenovska, Hana $u Department of Biomaterials and Bioanalogous System, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Proks, Vladimir $u Department of Biomaterials and Bioanalogous System, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Ciacci, Joseph D $u Department of Neurosurgery, School of Medicine, University of California, San Diego, La Jolla, CA, USA
700    1_
$a Marsala, Martin $u Department of Anesthesiology, School of Medicine, University of California, San Diego, La Jolla, CA, USA $1 https://orcid.org/0000000150486422
773    0_
$w MED00001075 $t Cell transplantation $x 1555-3892 $g Roč. 32, č. - (2023), s. 9636897231163232
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36959733 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171640 $b ABA008
999    __
$a ok $b bmc $g 1925014 $s 1190885
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 32 $c - $d 9636897231163232 $e - $i 1555-3892 $m Cell transplantation $n Cell Transplant $x MED00001075
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace